Addition of MeOTf (OTf = CF3SO3) to complexes of the type W(CO)(acac)2(η2-NCR) (acac = acetylacetonate) [R = Ph (1a), Me (1b)] yields cationic iminoacyl triflate salts of the type [W(CO)(acac)2(η2-MeNCR)][OTf]. Complexes 2a and 2b undergo nucleophilic attack at the iminoacyl carbon with Na[HB(OMe)3] or MeMgBr to form neutral η2-imine complexes of the type W(CO)(acac)2[η2-MeNC(Nuc)R] [Nuc = H (3a, 3b), Me (4)]. Hydride addition to 2b results in W(CO)(acac)2(η2-MeNCHMe), 3b, a complex that exhibits interconversion of diastereomers at ambient temperature on the NMR time scale. X-ray structures of cationic iminoacyl complex 2a and neutral imine complex 4 confirm η2-CN bonding of both the iminoacyl and imine ligands.
Cationic iminoacyl-carbonyl tungsten complexes of the type [W(CO) (eta (2)-MeNCR)(acac) 2] (+) (acac = acetylacetonate; R = Ph ( 1a), Me ( 1b)) easily undergo thermal substitution of CO with two-electron donors to yield [W(L)(eta (2)-MeNCR)(acac) 2] (+) (L = tert-butylisonitrile [R = Ph ( 2a), Me ( 2b)], 2,6-dimethylphenylisonitrile [R = Me ( 2c)], triphenylphosphine [R = Ph ( 3a), Me ( 3c)], and tricyclohexylphosphine [R = Ph ( 3b)]). Tricyclohexylphosphine complex 3b exhibits rapid, reversible phosphine ligand exchange at room temperature on the NMR time scale. Photolytic replacement of carbon monoxide with either phenylacetylene or 2-butyne occurs efficiently to form [W(eta (2)-alkyne)(eta (2)-MeNCR)(acac) 2] (+) complexes ( 5a- d) with a variable electron donor eta (2)-alkyne paired with the eta (2)-iminoacyl ligand in the W(II) coordination sphere. PMe 3 adds to 1a or 5b to form [W(L)(eta (2)-MeNC(PMe 3)Ph)(acac) 2] (+) [L = CO ( 4), MeCCMe ( 6)] via nucleophilic attack at the iminoacyl carbon. Addition of Na[HB(OMe) 3] to 5b yields W(eta (2)-MeCCMe)(eta (2)-MeNCHPh)(acac) 2, 8, which exhibits alkyne rotation on the NMR time scale. Addition of MeOTf to 8 places a second methyl group on the nitrogen atom to form an unusual cationic eta (2)-iminium complex [W(eta (2)-MeCCMe)(eta (2)-Me 2NCHPh)(acac) 2][OTf] ( 9[OTf], OTf = SO 3CF 3). X-ray structures of 2,6-dimethylphenylisonitrile complex 2c[BAr' 4 ], tricyclohexylphosphine complex 3b[BAr' 4 ], and phenylacetylene complex 5a[BAr' 4 ] confirm replacement of CO by these ligands in the [W(L)(eta (2)-MeNCR)(acac) 2] (+) products. X-ray structures of alkyne-imine complexes 6[BAr' 4 ] and 8 show products resulting from nucleophilic addition at the iminoacyl carbon, and the X-ray structure of 9[BAr' 4 ] reflects methylation at the imine nitrogen to form a rare eta (2)-iminium ligand.
Tungsten(IV) bis(acetylacetonate) (acetylacetonate = acac) complexes were synthesized by incorporating either a diazoalkane or an oxo ligand into the coordination sphere of a tungsten(II) reagent. The reaction of free diazoalkane (N 2 CRR′) with W(CO) 3 (acac) 2 leads to loss of two carbon monoxide ligands and coordination of the diazoalkane reagent through the terminal nitrogen to produce W(CO)(acac) 2 (N 2 CRR′). This monomer is best formulated as a tungsten(IV) complex. A second example of converting a d 4 tungsten carbonyl complex to a d 2 product involves oxidation of W(CO)(acac) 2 (PhCN) with m-chloroperoxybenzoic acid (MCPBA) to replace the CO ligand with an oxygen atom. This increase in metal oxidation state causes rotation of the nitrile ligand by 90°relative to the two bidentate acac ligands. Electrophilic addition at the nitrogen of the π-bound nitrile ligand using methyl triflate (MeOTf) and subsequent nucleophilic addition at carbon with sodium trimethoxyborohydride, Na[HB(OMe) 3 ], reduces the CN bond stereoselectively and produces the neutral imine complex W(O)(acac) 2 (PhHCNMe) with a diastereomeric ratio of 11:1.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.